Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Unipath OTC birth control system in development with clinical trials under way.

This article was originally published in The Tan Sheet

Executive Summary

UNIPATH OTC BIRTH CONTROL SYSTEM IN DEVELOPMENT with the initiation of clinical trials in seven U.S. cities. Enrollment of a planned 1,200 couples into the research program began June 5. The system is based on a hormone analysis technology similar to that in the company's Clearblue Easy home pregnancy test and Clearplan Easy home ovulation test. However, the birth control system differs from ovulation tests in that it enables women to identify their entire fertile phase and not just peak fertility, according to Unipath Diagnostics.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087163

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel